MARKET

DYNT

DYNT

Dynatronics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.320
-0.030
-2.22%
Closed 17:51 09/17 EDT
OPEN
1.390
PREV CLOSE
1.350
HIGH
1.390
LOW
1.320
VOLUME
234.69K
TURNOVER
--
52 WEEK HIGH
2.560
52 WEEK LOW
0.5230
MARKET CAP
22.92M
P/E (TTM)
-4.5299
1D
5D
1M
3M
1Y
5Y
Dynatronics Corporation Schedules Conference Call and Webcast to Report Results for Fourth Quarter and Fiscal Year 2021
EAGAN, MN / ACCESSWIRE / September 9, 2021 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its fourth q...
ACCESSWIRE · 09/09 12:01
54 Stocks Moving In Tuesday's Mid-Day Session
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
Benzinga · 08/10 16:02
Dynatronics Stock Is Trading Higher On Interim Q4 Sales Beating Wall Street Consensus
Benzinga · 08/10 13:00
FCEL, MVST and ASTR among pre market gainers
Lightning eMotors ZEV +44% on signing largest contract ever in the electric shuttle bus market with Forest River Fulcrum Therapeutics FULC +53% on early-stage results for sickle cell disease therapy IMV IMV +39% on promising maveropepimut-S
Seekingalpha · 08/10 12:55
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Benzinga · 08/10 12:07
Dynatronics Sees Higher Fiscal Q4 Sales
MT Newswires · 08/10 11:04
28 Stocks Moving in Tuesday's Pre-Market Session
Gainers
Benzinga · 08/10 11:02
Dynatronics zooms 21% on guiding Q4 above consensus
Dynatronics (NASDAQ:DYNT) reports preliminary 4Q21 total net sales of ~$12.1M vs. $9.90M consensus. Q4 continued product net sales from products Dynatronics will continue to offer to customers were ~$9.7M. As
Seekingalpha · 08/09 21:08
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DYNT. Analyze the recent business situations of Dynatronics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DYNT stock price target is 2.000 with a high estimate of 2.250 and a low estimate of 1.650.
EPS
Institutional Holdings
Institutions: 21
Institutional Holdings: 1.99M
% Owned: 11.43%
Shares Outstanding: 17.36M
TypeInstitutionsShares
Increased
5
108.89K
New
3
102.20K
Decreased
2
8.03K
Sold Out
1
16.61K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.54%
Healthcare Equipment & Supplies
+0.65%
Key Executives
Chairman/Independent Director
Erin Enright
Chief Executive Officer/Director
John Krier
Chief Financial Officer
Norman Roegner
Chief Accounting Officer
Skyler Black
Vice President/Director of Marketing
Sarah Rome - Mealman
Vice President
George Murray
Vice President
James Ogilvie
Vice President
R.J. Smith
General Counsel
Jennifer Keeler
Director of Sales
Ed Staten
Director
Brian Baker
Independent Director
David Holtz
Independent Director
Scott Klosterman
Independent Director
Brian Larkin
Independent Director
R. Scott Ward
No Data
About DYNT
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company's products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. Its physical medicine products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound; manufactured capital products, including traction systems and wood furniture; manufactured supplies, including cold packs, straps, wedges, bolsters and mats; distributed capital products, including hydrotherapy, weight training equipment and pilates, and distributed supplies, including clinical accessories, sports med and taping products, lotions and gels.

Webull offers kinds of Dynatronics Corporation stock information, including NASDAQ:DYNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DYNT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DYNT stock methods without spending real money on the virtual paper trading platform.